Skip to main content

Allergic reactions: life-threatening symptoms versus counting body systems

Question #85

Does involvement of two body systems automatically require epinephrine for an allergic reaction? How should paramedics assess symptoms such as hives, angioedema and a single episode of vomiting?

Answer:

CEPCP’s approach is to identify a life-threatening allergic reaction, rather than require involvement of two body systems. In the context of an allergic reaction, hypotension alone or a developing airway obstruction can be enough to warrant epinephrine, even when there are no symptoms in a second system (Central East Prehospital Care Program, 2025).

When several systems are involved, the same principle applies: consider whether the symptoms represent a life threat or a developing threat. Itchiness with mild nausea is quite different from repeated vomiting and profuse diarrhea that are causing significant fluid loss. The severity and progression of the reaction matter more than the number of systems involved, which is consistent with international guidance on recognizing anaphylaxis (Cardona et al., 2020).

In the example you describe, the key question is whether the angioedema is threatening the airway or progressing toward that point. Assess where the swelling is occurring and how it is affecting the patient’s voice, swallowing and breathing, rather than relying on the label “moderate.” The hives and single episode of vomiting do not automatically make the reaction life-threatening. In this case, the location and progression of the swelling are particularly important in deciding whether epinephrine is needed.

The treating paramedic needs to use clinical judgment to identify the life threat, explain the findings that support it and document the reasoning for treatment. Continue reassessing as the reaction evolves, and treat a developing threat without waiting for established shock or complete airway obstruction.

References

Central East Prehospital Care Program. (2025, August 28). Defining anaphylaxis (MedicASK Question 51). https://cepcp.myobh.ca/medicaskform/medicask-category-view/13-medical-directives/35-moderate-to-severe-allergic-reaction-se/110-defining-anaphylaxis.html

Cardona, V., Ansotegui, I. J., Ebisawa, M., El-Gamal, Y., Fernandez Rivas, M., Fineman, S., Geller, M., Gonzalez-Estrada, A., Greenberger, P. A., Sanchez Borges, M., Senna, G., Sheikh, A., Tanno, L. K., Thong, B. Y., Turner, P. J., & Worm, M. (2020). World Allergy Organization anaphylaxis guidance 2020. World Allergy Organization Journal, 13(10), Article 100472. https://doi.org/10.1016/j.waojou.2020.100472

Medical Directive Category

Moderate to Severe Allergic Reaction (SE)

Published

24 October 2026

ALSPCS Version

5.4

Views

4

Please reference the MOST RECENT ALS PCS for updates and changes to these directives.